The CQUIN Learning Network: Partnering to Advance Differentiated Care

Slides:



Advertisements
Similar presentations
Preliminary findings of a routine PMTCT Option B+ programme in a rural district in Malawi Rebecca M. Coulborn 1, Laura Triviño Duran 1, Carol Metcalf 2,
Advertisements

1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
Management and Development for Health (MDH)
Progress toward COP 12 targets Mozambique-ICB October
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
ICAP Track 1.0 Year 6: Reaching Targets Focus on Quality Continued Innovations David Hoos, MD, MPH Dar es Salaam August 4, 2009.
Data dissemination meeting February 28, 2007 ICAP New York.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Progress toward COP 12 targets DRC October
PMTCT - The Platform for integrating HIV/AIDS Services in the MCH Clinic. Bola Oyeledun, MD, MPH Track 1.0 Partners Meeting Washington DC. August 2008.
WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.
MATERNAL ANTIRETROVIRAL THERAPY AND INFANT OUTCOMES THROUGHOUT THE FIRST YEAR OF LIFE: results from the DREAM study in Dschang, Cameroon Taafo F, Doro.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
1 Predictors of Immunological Failure Among Adult Patients Receiving ART at an urban, HIV Clinic in Uganda Dr. Muhumuza Simon (M.D, MPH) Mulago-Mbarara.
CQUIN: The HIV Coverage, Quality, and Impact Network Miriam Rabkin, MD, MPH Director for Health Systems Strategies ICAP Columbia University.
Daouda Diouf Executive Director Enda Santé Dakar, Senegal
ADVANCING HIV NURSING PRACTICE IN THE COMMUNITY
Treatment as prevention: policy and programmatic considerations
The CQUIN Learning Network: Partnering to Advance Differentiated Care
Quick Review This presentation is the first in a series of presentations intended to familiarize you with disparities calculation Part I: YOU ARE HERE!
Monday November 30th 2015 ,Harare Zimbabwe
Differentiated Monitoring & Evaluation
How differentiated care supports “Tx all” and Dr
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
The CQUIN Learning Network: Partnering to Advance Differentiated Care
TITLE Differentiated Care for People who inject Drugs, Men who have sex with men, Sex workers, Transgender people, Prisoners and other people living in.
Pregnancy and living with HIV
Earlier treatment and lower mortality in infants Initiating ART at
Acceptability of early HIV treatment among South Africa women N Garrett, E Norman, V Asari, N Naicker, N Majola, K Leask, Q Abdool Karim and SS Abdool.
Differentiated Service Delivery: Innovating for Impact
Addressing the challenges and successes of expediting TB treatment among PLHIV who are seriously ill: experience from Kenya Masini E & Olwande C National.
Participants 18year old+
Daniel Meressa, M.D. Global Health Committee St. Peter’s Hospital
Zimbabwe’s shift towards treat all: national country context
2017 Key Considerations for adolescents and children & Key populations
Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
1University of Maryland; 2Futures Group International; 3CDC; 4USAID
MHEALTH to Improve Health: Effectiveness of a weekly text messaging intervention to improve ART adherence and HIV Viral Load: WelTel OAKTREE. M.C.M. Murray1,2,3,
Implementation of the Appointment Spacing Model of Differentiated Service Delivery in Ethiopia: Successes and Challenges Tamrat Assefa1, Zenebe Melaku1,
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
The use of cotrimoxazole prophylaxis in the context of HIV infection
Taking DSD to Scale in Zimbabwe
“Time to Focus: Doing things better and differently for key populations” Partner notification HIV Self Testing and Social Network Testing Dr Irene.
The role of CD4 in patient monitoring Amsterdam July 2018
The Cost of Differentiated Service Delivery: A Systematic Review
Advanced HIV: a WHO perspective
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Mapping the Scale-Up of DSD: A 13-Country Health Facility Survey
Effect of POC CD4 testing at HIV diagnosis on attrition prior to ART initiation among youth in Khayelitsha, South Africa Pre-treatment losses to care remains.
Wafaa El-Sadr, MD, MPH, MPA ICAP at Columbia University
24 July 2018 Treatment outcomes with bedaquiline use when substituted for second-line injectables in multidrug resistant tuberculosis: a retrospective.
Fatima Oliveira Tsiouris Deputy Director, Clinical & Training Unit
Dr. Proscovia Namuwenge Senior program Officer Tbhiv- moh
Indian Scenario HIV Situation TB Situation
Management and Development for Health (MDH)
Community ART for Retention in Zambia: Fast Track Model
Multi-disease diagnostic integration
Illustrative Cluster Detection and Response Strategy
TB Screening and Differentiated Service Delivery: State of the Art
KATUREEBE CORDELIA, MBchB, MMED Pead
DSD and TB/HIV services in Zimbabwe
CQUIN Call to Action Peter Preko MB, ChB Project Director, CQUIN
Stakeholder engagement and research utilization: Insights from Namibia
Jessica Justman, MD Senior Technical Director ICAP at Columbia
Andreas D. Haas, PhD Postdoctoral fellow, ICAP at Columbia University
Why Quality Matters in ART Programs
For a healthy Zambia.
Treatment Outcome among patients on ART in Southern Tanzania: Does Time of ART initiation Matter?
Presentation transcript:

The CQUIN Learning Network: Partnering to Advance Differentiated Care Differentiated Care for Individuals at High Risk of Disease Progression Dr. Maureen Syowai Kathuku-Kaati ICAP Kenya IAS Satellite Meeting, July 23, 2017

CQUIN: The HIV Learning Network Outline Defining “high risk” Why do people at high risk need DSDM? Experience from Kenya CQUIN: The HIV Learning Network

CQUIN: The HIV Learning Network Outline Defining “high risk” Why do people at high risk need DSDM? Experience from Kenya CQUIN: The HIV Learning Network

CQUIN: The HIV Learning Network Defining “High Risk” CQUIN: The HIV Learning Network

CQUIN: The HIV Learning Network Defining “High Risk” Presenting with advanced disease CD4 < 200 cells/mm3 WHO stage 3 or 4 “Unstable” on ART, e.g. on ART for > 1 year but Not virally suppressed Advanced immunosuppression Adverse drug reactions Active opportunistic infection Nonadherent to ART Substance use Mental illness CQUIN: The HIV Learning Network

Why Focus on Patients at High Risk? The proportion of people starting ART in LMIC with CD4 < 200 is falling, but remains high (30-40%) Mortality amongst this population is high, particularly in the first 3-6 months on ART (8-26% in SSA) Systems and strategies for patients on ART but virally unsuppressed (patients with “unstable” HIV) lack a robust evidence base

CQUIN: The HIV Learning Network Outline Defining “high risk” Why do people at high risk need DSDM? Experience from Kenya CQUIN: The HIV Learning Network

DSD Extends Beyond Stable Patients

Programmatic Challenges

Illustrative Programmatic Challenges How can we swiftly identify P@HR and “flag” them for rapid and prioritized services? How can we provide services that are both intensified and patient-centered?

DSDM for P@HR SERVICE FREQUENCY SERVICE INTENSITY SERVICE LOCATION Weekly or biweekly visits? Enhanced prophylaxis? Enhanced counseling? SERVICE LOCATION SERVICE PROVIDERS Specialty clinics? Intermediate care facilities? Housing near facility (like maternity waiting homes)? Home-based care? NIMART “plus”? Super-mentors in Kenya Oversight committees

CQUIN: The HIV Learning Network Outline Defining “high risk” Why do people at high risk need DSDM? Experience from Kenya: patients with advanced HIV CQUIN: The HIV Learning Network

CD4 Distribution at Enrolment in Kenya CD4 Distribution at enrolment among PLHIV > 5 yrs enrolled in 2015 PLHIV with CD4 count of 0 to 249 cells/mm3 represented 35% of the population CD4 Distribution at enrolment by age group among PLHIV > 5 yrs enrolled in 2015 Late entry into care for PLHIV 10-14 yrs, and PLHIV > 35 yrs Source: NASCOP National Data Warehouse CQUIN: The HIV Learning Network

CQUIN: The HIV Learning Network 2015 Cohort 12 Month Outcomes 2015 12 Month Pre-ART Cohort Outcomes Overall mortality of 1% 2015 Cohort 12 month ART outcomes by baseline CD4 5 % mortality for 0-249 CD4 count CQUIN: The HIV Learning Network

ICAP in Kenya Program At the end of September 2015, ICAP in Kenya program data review revealed an increase in mortality and lost to follow-up among PLHIV Reviewed program data for PLHIV initiated on ART at 62 ICAP supported facilities from January 2013 to December 2013 Assessed patient outcomes for PLHIV with CD4 < 100 cells/mm3 at 6 months and 12 months after ART initiation

CD4 Count and TB Status at ART Initiation (62 facilities) Data source: C-PAD

Treatment Outcomes for Severely Immunosuppressed PLHIV (n=479)

Survival Analysis Expanded the analysis further to patients with 80 months follow-up time after enrolment into care at ICAP-supported facilities Conducted a Kaplan Meier Survival analysis and further disaggregated the data by CD4 count and by age of patient at the time of enrolment into care

Survival Analysis Stratified by CD4 Mortality is highest for clients enrolled with CD4 <100 cells/ml Data source: C-PAD

Survival Analysis Stratified by Age Mortality does not significantly differ by enrollment age (p>0.05) Infants (<1 yr.) have a higher relative mortality rate compared to other age groups Data source: C-PAD

Modified Approach to Patient with Severe Immunosuppression

CQUIN: The HIV Learning Network Conclusion Other Care Models for Patients at High Risk of Disease Progression in SSA REALITY study Lighthouse ALUP model In spite of convincing evidence, the quality and coverage of DSDM for P@HR is substandard There is need to take the opportunities presented by these models to scale CQUIN provides an opportunity to move from policy to practice CQUIN: The HIV Learning Network